NCT00450450 · OUTCOME

Estimated Median Length of Initial Hospitalization

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Up to 10 years

What was measured

Estimated and compared between randomization arms using the Wilcoxon rank-sum test.

Analysis population: Data regarding length of Initial Hospitalization are not collected for this study according to Study Chair.

Groups in this outcome

Control BM Arm

Conventional bone marrow transplant (BM)

Experimental G-BM Arm

G-CSF (filgrastim) stimulated bone marrow (G-BM)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Control BM Arm	0
Experimental G-BM Arm	0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denoms

counts
group Id
OG000
value
0
group Id
OG001
value
0
units
Participants

description

Estimated and compared between randomization arms using the Wilcoxon rank-sum test.

groups

description
Conventional bone marrow transplant (BM)
id
OG000
title
Control BM Arm
description
G-CSF (filgrastim) stimulated bone marrow (G-BM)
id
OG001
title
Experimental G-BM Arm

population Description

Data regarding length of Initial Hospitalization are not collected for this study according to Study Chair.

reporting Status

POSTED

time Frame

Up to 10 years

title

Estimated Median Length of Initial Hospitalization

type

SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice